- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00072891
Improving Medication Adherence in Comorbid Conditions
February 12, 2010 updated by: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
This study is designed to study how adults with Type 2 Diabetes and either high blood pressure and/or high blood cholesterol manage their treatment regimen.
It is also called the Diabetes Management Study.
Individuals need to be 40 years of age or older and on oral medication (pills) management for two of the three conditions of interest.
They may also be on other treatment such as insulin, diet and/or exercise programs.
Individuals will be followed for approximately 12 months.
About 1/4 of the persons in the study will receive a telephone counseling program with a nurse focused upon their management of their treatment program.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment
400
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Pennsylvania
-
Pittsburgh, Pennsylvania, United States, 15261
- University of Pittsburgh School of Nursing
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
40 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
- Type 2 diabetes mellitus, hypertension and/or hyperlipidemia,
- On oral medication for two of the above conditions,
- Manage own medications,
- Must have access to a telephone,
- Not participating in other adherence education or counseling trials
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Completion (Actual)
December 1, 2005
Study Registration Dates
First Submitted
November 12, 2003
First Submitted That Met QC Criteria
November 13, 2003
First Posted (Estimate)
November 14, 2003
Study Record Updates
Last Update Posted (Estimate)
February 15, 2010
Last Update Submitted That Met QC Criteria
February 12, 2010
Last Verified
February 1, 2010
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 59048DK (completed)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypertension
-
National Taiwan University Hospital Hsin-Chu BranchRecruitingHypertension,Essential | Hypertension, MaskedTaiwan
-
University of Alabama at BirminghamTroy UniversityCompletedHypertension | Hypertension, Resistant to Conventional Therapy | Uncontrolled Hypertension | Hypertension, White CoatUnited States
-
BayerCompletedPrimary HypertensionChina
-
Addpharma Inc.Completed
-
Columbia UniversityAgency for Healthcare Research and Quality (AHRQ)Active, not recruitingWhite Coat Hypertension | Hypertension,EssentialUnited States
-
Universidade Federal de Santa MariaCompletedHealthy Volunteers | Hypertension, EssentialBrazil
-
Sheffield Teaching Hospitals NHS Foundation TrustUniversity of SheffieldCompletedIdiopathic Pulmonary Arterial Hypertension | Chronic Thromboembolic Pulmonary HypertensionUnited Kingdom
-
Sulaiman AlRajhi CollegesUnknownHypertension, Essential | β-hydroxybutyrate
-
China Academy of Chinese Medical SciencesGuang'anmen Hospital of China Academy of Chinese Medical SciencesCompletedHypertension, Resistant to Conventional Therapy | Primary HypertensionChina
Clinical Trials on telephone counseling
-
University of California, IrvineNational Cancer Institute (NCI); National Institutes of Health (NIH)Completed
-
Northwestern UniversityDiabetes Action Research and Education FoundationCompletedDiabetes Mellitus, Type 2 | Diabetes ComplicationsUnited States
-
American Academy of Family PhysiciansRobert Wood Johnson Foundation; Agency for Healthcare Research and Quality...CompletedSmoking | Physical Activity | Diet | Alcohol AbuseUnited States
-
German Cancer Research CenterGerman Federal Ministry of Education and Research; Heidelberg UniversityCompletedType 2 Diabetes MellitusGermany
-
Mayo ClinicCompletedTobacco CessationUnited States
-
Georgetown UniversityHackensack Meridian HealthCompletedBreast Cancer | Hereditary Breast CancerUnited States
-
VA Office of Research and DevelopmentCompleted
-
University of ArizonaNational Cancer Institute (NCI)Completed
-
Kaiser PermanenteNational Cancer Institute (NCI)Completed
-
Indiana UniversityNational Cancer Institute (NCI); American Cancer Society, Inc.; Indiana University...CompletedLung CancerUnited States